US 11376273
Modulation of factor 11 expression
granted A61KA61K31/366A61K31/4365
Quick answer
US patent 11376273 (Modulation of factor 11 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/366, A61K31/4365, A61K31/4545, A61K31/7125